← Leaderboards
David G. Gorenstein
University Of Texas Medical Br Galveston
$9,982,840
Attributed
$12,998,827
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$22,702,584 · 13
By mechanism
U54$10,772,578 · 2
U01$6,063,927 · 1
RC2$3,001,830 · 1
R01$2,429,785 · 3
T32$301,044 · 1
R03$73,311 · 1
Top collaborators
- Mauro Ferrari7 shared
- Gabriel Lopez-Berestein7 shared
- Anil K Sood7 shared
- Jennifer L West5 shared
- Wah Chiu3 shared
- Paolo Decuzzi3 shared
- Rebekah A. Drezek3 shared
- Jim Klostergaard3 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Roberto P Garofalo$6,746,389
- Krishna Rajarathnam$6,979,683
- Istvan Steven Boldogh$9,318,184
- Lynn Soong$9,725,492
- David H Walker$27,320,724
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsBaseOligonucleotidesLibrariesAffinityTechnologyResourcesAptamerIn VitroCellsInterestLigandsComplexUnited States National Institutes Of HealthBinding (Molecular Function)NucleocapsidPharmaceutical PreparationsPropertyVertebral ColumnGoldCombinatorialBiologicalLaboratoriesCost
Grant awards (35)
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells$396,465
R01 · FY2014 · DE
Targeting Core$206,559
U54 · FY2014 · CA · contact PI
Texas Center for Cancer Nanomedicine$1,850,049
U54 · FY2013 · CA · contact PI
Targeting Core$288,369
U54 · FY2013 · CA · contact PI
Texas Center for Cancer Nanomedicine$2,538,514
U54 · FY2012 · CA · contact PI
Targeting Core$212,502
U54 · FY2012 · CA · contact PI
Texas Center for Cancer Nanomedicine$2,579,927
U54 · FY2011 · CA · contact PI
Targeting Core$179,501
U54 · FY2011 · CA · contact PI
LARGE PARTICLE SORTING FOR THE SELECTION OF OPTIMAL APTAMER BINDERS$11,187
P41 · FY2011 · RR · contact PI
Texas Center for Cancer Nanomedicine$2,735,267
U54 · FY2010 · CA · contact PI
Subcellular localization of nanoparticles$993,315
RC2 · FY2010 · GM
Subcellular localization of nanoparticles$495,098
RC2 · FY2010 · GM
Role of Nitric Oxide and Cyclic GMP in Stem Cells$279,329
R01 · FY2010 · GM · contact PI
Targeting Core$181,890
U54 · FY2010 · CA · contact PI
LARGE PARTICLE SORTING FOR THE SELECTION OF OPTIMAL APTAMER BINDERS$16,711
P41 · FY2010 · RR · contact PI
Subcellular localization of nanoparticles$1,513,417
RC2 · FY2009 · GM
Role of Nitric Oxide and Cyclic GMP in Stem Cells$282,150
R01 · FY2009 · GM · contact PI
LARGE PARTICLE SORTING FOR THE SELECTION OF OPTIMAL APTAMER BINDERS$16,109
P41 · FY2009 · RR · contact PI
LARGE PARTICLE SORTING FOR THE SELECTION OF OPTIMAL APTAMER BINDERS$16,102
P41 · FY2008 · RR · contact PI
Biodefense Proteomics Collaboratory$638,375
U01 · FY2007 · AI · contact PI
Biodefense Proteomics Collaboratory$512,817
U01 · FY2007 · AI · contact PI
Computational and Structural Biology in Biodefense$103,542
T32 · FY2007 · AI · contact PI
Combinatorial Selection of Beta-Catenin/T Cell Factor Pathway Inhibitors$72,702
R03 · FY2007 · CA · contact PI
Combinatorial Selection of Beta-Catenin/T Cell Factor Pathway Inhibitors$609
R03 · FY2007 · CA · contact PI
Biodefense Proteomics Collaboratory$1,235,755
U01 · FY2006 · AI · contact PI
Computational and Structural Biology in Biodefense$93,960
T32 · FY2006 · AI · contact PI
Biodefense Proteomics Collaboratory$1,231,661
U01 · FY2005 · AI
Computational and Structural Biology in Biodefense$103,542
T32 · FY2005 · AI
Biodefense Proteomics Collaboratory$1,230,272
U01 · FY2004 · AI
COMBINATORIAL &RATIONAL DESIGN APTAMERS TARGETING HIV$312,021
R01 · FY2004 · AI
Biodefense Proteomics Collaboratory$1,215,047
U01 · FY2003 · AI
COMBINATORIAL &RATIONAL DESIGN APTAMERS TARGETING HIV$302,935
R01 · FY2003 · AI
COMBINATORIAL &RATIONAL DESIGN APTAMERS TARGETING HIV$294,110
R01 · FY2002 · AI
COMBINATORIAL &RATIONAL DESIGN APTAMERS TARGETING HIV$285,547
R01 · FY2001 · AI
COMBINATORIAL &RATIONAL DESIGN APTAMERS TARGETING HIV$277,228
R01 · FY2000 · AI